Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Levofloxacin: High-dose, short-course for bacterial infection28 April, 2019Associate Professor Panpit Suwangool Bangkok Hospital, Thailand Levofloxacin is a well-established antibacterial for respiratory and urinary tract infections.1 Levofloxacin is active against... -
Oral sitafloxacin vs intravenous ceftriaxone for the treatment of acute pyelonephritis and complicated urinary tract infection9 April, 2019An open-label randomised, controlled, noninferiority clinical trial has shown that oral sitafloxacin is noninferior to intravenous (IV) ceftriaxone followed by oral cefdinir for the treatment of... -
Levofloxacin remains as one of the core agents in the treatment of tuberculosis2 April, 2019According to the current World Health Organization (WHO) guidelines (2016 update), fluoroquinolones including moxifloxacin, gatifloxacin, and levofloxacin are important second-line... -
First malaria saliva test identifies malaria parasites20 March, 2019Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were... -
Oral levofloxacin and intravenous vancomycin for bacteraemia due to Microbacterium paraoxydans13 March, 2019A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin... -
Levofloxacin for lower lobe pneumonia presenting as persistent hiccups7 March, 2019Levofloxacin has been shown to resolve a case of community-acquired pneumonia in an elderly patient presenting with persistent hiccups – without any typical symptoms, signs, or laboratory... -
2018 Taiwan’s pneumonia guidelines: What’s new?4 March, 2019Dr Susan Shin-Jung Lee, MD, PhD Associate Professor, National Yang Ming University, Taipei, Taiwan. Chief, Division of Infectious Diseases, Department of Internal Medicine; Chief,... -
Progress against malaria stalls28 February, 2019Despite the falling number of malaria cases globally from 2010 to 2015, the numbers have been plateauing for the second consecutive year – with 217 million cases in 2016 and an estimated 219... -
Oral sitafloxacin as a switch therapy for the treatment of non-bacteraemic acute pyelonephritis21 February, 2019A treatment regimen of carbapenem followed by sitafloxacin or ertapenem was found to be effective in patients with non-bacteraemic acute pyelonephritis caused by extended-spectrum... -
Managing mycobacterial infection after lung transplantation with levofloxacin: Case series11 February, 2019The combination of levofloxacin with isoniazid, pyrazinamide and ethambutol was found to be effective in managing mycobacterial infection in lung transplant recipients. The risk of...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Levofloxacin: High-dose, short-course for bacterial infection -
2018 Taiwan’s pneumonia guidelines: What’s new? -
Interview with Prof Wang Minggui -
Levofloxacin for the Management of Hospital-Acquired, Ventilator-Associated and Healthcare-Associated Pneumonia (Interview with Prof. Marin H. Kollef) -
The Use of Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (Interview with Prof. Hartmut Lode) -
Effect of Combination of Levofloxacin and Meropenem against Pseudomonas aeruginosa (Supervised by Prof. Kazuhiro Tateda, MD, PhD) -
Viewing Infectious Respiratory Disease (Supervised by Prof. Jiro Fujita, MD, PhD, ACCP) -
New Challenges for Levofloxacin in the Fight Against Infectious Diseases (Interviews with World-Renowned Experts) -
New Era for the Treatment of Respiratory Tract infections (Daiichi Pharmaceutical Co., Ltd., Special Interview) -
The Efficacy, Tolerability, and Benefits of 750 mg Once-Daily Levofloxacin in the Treatment of Community-Acquired Pneumonia (Interview with Prof. Thomas M. File, Jr, MD, MS )
UPCOMING EVENTS
05 June - 09 June, 2019
Washington, DC, USA, North America
07 July - 12 July, 2019
Glasgow, United Kingdom, Western Europe
16 September - 20 September, 2019
Liverpool, UK, Western Europe
